We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

79 hedge funds and large institutions have $113M invested in abrdn Life Sciences Investors in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $80.4M → $113M (+$32.6M)

39% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 23

7.41% more ownership

Funds ownership: 24.59% → 32% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

1% less funds holding

Funds holding: 80 → 79 (-1)

Holders
79
Holders Change
-1
Holders Change %
-1.25%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
32
Reduced
23
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$14.1M
2
CCP
Clough Capital Partners
Massachusetts
+$3.01M
3
CA
Cornerstone Advisors
North Carolina
+$2.58M
4
Morgan Stanley
Morgan Stanley
New York
+$2.45M
5
Bank of America
Bank of America
North Carolina
+$1.81M

Top Sellers

Rank Fund Capital Flow
1
TJHA
Thomas J. Herzfeld Advisors
Florida
-$1.43M
2
WAM
Wolverine Asset Management
Illinois
-$1.41M
3
LSC
Logan Stone Capital
Illinois
-$1.2M
4
Walleye Capital
Walleye Capital
New York
-$623K
5
Cohen & Steers
Cohen & Steers
New York
-$468K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
76
Atlas Capital Advisors
Wyoming
$1.86K – – –
SIC
77
Salem Investment Counselors
North Carolina
$1.68K +$1.54K +125 New
JWA
78
JFS Wealth Advisors
Pennsylvania
$41 – – –
HNB
79
Huntington National Bank
Ohio
$24 – – –
Fidelity Investments
80
Fidelity Investments
Massachusetts
$13 +$12 +1 New
Walleye Capital
81
Walleye Capital
New York
– -$623K -49,963 Closed
AW
82
Atlas Wealth
Ohio
– -$311K -24,969 Closed
KAS
83
KPP Advisory Services
Kentucky
– -$275K -22,028 Closed
PIA
84
Powell Investment Advisors
Florida
– -$159K -12,731 Closed
Invesco
85
Invesco
Georgia
– -$158K -12,652 Closed
BRWA
86
B. Riley Wealth Advisors
Florida
– -$143K -11,500 Closed
First Trust Advisors
87
First Trust Advisors
Illinois
– -$132K -10,547 Closed
IFG
88
Independent Financial Group
California
– -$125K -10,029 Closed
CSPIA
89
Cary Street Partners Investment Advisory
Virginia
– -$48.5K -3,893 Closed
BWS
90
Buck Wealth Strategies
Colorado
– -$6.15K -493 Closed
1 2 3
4

HQL Hedge Fund Activity: Q4 2023 in Review

79 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2023, worth a combined $113M — up 41% from $80.4M a quarter earlier.

Fund positioning in HQL was balanced in Q4 2023: 10 funds opened new positions, 10 closed out, 32 added to existing stakes and 23 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $14.1M. The largest seller was Thomas J. Herzfeld Advisors, cutting an estimated $1.43M.

  • 79 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2023, down from 80 in Q3 2023.
  • Funds reported $113M of abrdn Life Sciences Investors stock for Q4 2023, up 41% quarter-over-quarter.
  • 10 funds opened new abrdn Life Sciences Investors positions in Q4 2023 and 10 closed out, a net change of 0 holders.
  • The largest abrdn Life Sciences Investors buyer in Q4 2023 was Saba Capital Management, an estimated $14.1M added.
  • The largest abrdn Life Sciences Investors seller in Q4 2023 was Thomas J. Herzfeld Advisors, an estimated $1.43M sold.

Based on aggregated 13F filings for Q4 2023.